Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ligand Pharmaceuticals (LGND) over the last 15 years, with Q3 2025 value amounting to 0.21.

  • Ligand Pharmaceuticals' Asset Utilization Ratio rose 2377.26% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year increase of 2377.26%. This contributed to the annual value of 0.19 for FY2024, which is 1409.27% up from last year.
  • According to the latest figures from Q3 2025, Ligand Pharmaceuticals' Asset Utilization Ratio is 0.21, which was up 2377.26% from 0.2 recorded in Q2 2025.
  • Ligand Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.26 during Q1 2023, with a 5-year trough of 0.14 in Q1 2024.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.19 (2022), whereas its average is 0.19.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 8335.17% in 2021, then tumbled by 4626.81% in 2024.
  • Over the past 5 years, Ligand Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.19 in 2021, then increased by 15.21% to 0.22 in 2022, then dropped by 22.05% to 0.17 in 2023, then grew by 4.45% to 0.18 in 2024, then increased by 17.55% to 0.21 in 2025.
  • Its Asset Utilization Ratio was 0.21 in Q3 2025, compared to 0.2 in Q2 2025 and 0.2 in Q1 2025.